MAZUMDAR CLAIRE (Chief Executive Officer) sold 4.0% of their position (15K shares) of BICARA THERAPEUTICS INC. on the open market
Open‑market sale worth $300.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 5/20/2026ACC: 0001628280-26-036885
DirectorOfficer· Chief Executive Officer
Since Mar 2026
-15K
Net shares
Net seller
$300.6K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
15K acquired · 30K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+15K
Price / share
$3.79
Trade value
$56.85K
% of position
4.1%
5/18/2026
362.15K→377.15K
Common Stock
Direct
Shares
−12.02K
Price / share
$19.96
Trade value
$239.98K
% of position
3.2%
5/18/2026
377.15K→365.13K
Common Stock
Direct
Shares
−2.98K
Price / share
$20.35
Trade value
$60.60K
% of position
0.8%
5/18/2026
365.13K→362.15K
Total
Net shares
+0.00
Net value
-$243.73K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/18/2026 | M · Option Exercise | +15K | $3.79 | $56.85K | 4.1% | 362.15K | 377.15K |
| Common Stock Direct | 5/18/2026 | S · Sale | −12.02K | $19.96 | $239.98K | 3.2% | 377.15K | 365.13K |
| Common Stock Direct | 5/18/2026 | S · Sale | −2.98K | $20.35 | $60.60K | 0.8% | 365.13K | 362.15K |
| Total | +0.00 | -$243.73K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
15K shares
Shares
−15K
Strike price
3.7898
Held after
146.11K
Exercisable
—
5/18/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock15K shares | 5/18/2026 | M · Option Exercise | −15K | 3.7898 | — | 146.11K |